Nothing comparable since the round — shown at its seed round, Feb 2025 ($30.0M post-money).
- ·2 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Myosin Therapeutics funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2022 | Seed Round | $3.0M | ▮ | ▮ |
Membership and data by Private Market View
Myosin Therapeutics valuation
Myosin Therapeutics is valued at approximately $30 million as of Oct 2026. The figure is set by institutional fund marks. The reference point is its seed round in Feb 2025, at a $30 million post-money valuation.
How much has Myosin Therapeutics raised?
Myosin Therapeutics has raised $6.9 million in total; 1 of its rounds is on record. The largest on record was a $3 million seed round in Dec 2022.
Myosin Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in Mar 2023 ($3 million sold to 4 investors).
Institutional holders and vehicles
1 SEC-registered fund reported 2 fair-value marks on Myosin Therapeutics for May 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Myosin Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Myosin Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Myosin Therapeutics
- What is Myosin Therapeutics worth?
- Myosin Therapeutics is valued at $30.0M as of Oct 2026. Nothing comparable since the round — shown at its seed round, Feb 2025 ($30.0M post-money).
- How much has Myosin Therapeutics raised?
- Myosin Therapeutics has raised $6.9M in total funding across 1 recorded rounds.
- When did Myosin Therapeutics last raise?
- Myosin Therapeutics last raised in Dec 2022 (Seed Round), raising $3.0M.